Related Experiment Video
Updated: Dec 3, 2025

The MultiBac Protein Complex Production Platform at the EMBL
Published on: July 11, 2013
Swiss Startup Framework: A Highly Effective Network Supporting the Generation of Emerging Biotech Businesses
Isabelle Mitchell1, Stefan Steiner2, Michael Altorfer3
1Venture Kick, Wiesenstrasse 5, CH-8952 Schlieren, Switzerland.
Abstract:
For over 50 years, Switzerland has been one of the leading countries driving innovation in biotechnology and its industrial applications. Today, some 1,000 biotech companies form a tightly knit, cross-functional network ranging from research through to manufacturing. This network comprises R&D companies, contract research organizations, and highly specialized advisors and biotech investors. Together, they form an external innovation pool that complements the in-house R&D capacity of the large multi-national pharma companies. A highly effective startup framework, solid acceleration mechanisms, and innovative investors enable the emergence of a continuous flow of biotech startups that revitalize the industry with new technologies and products supporting drug development and diagnostics.
More Related Videos
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Drug Products: Biologics, Biosimilars and Interchangeables
Preclinical Development: Overview
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

